Abstract:Osteoporosis (OP), as a chronic and complex metabolic bone disease, is centred on disturbances in the bone microcirculatory system, which exacerbates bone loss and damage to the microstructure of bone tissue, resulting in increased bone fragility. Typical clinical manifestations include persistent low back pain, a significant increase in fracture risk, and marked changes in spinal morphology, all of which have a serious impact on patients' quality of life. The incidence of osteoporosis (OP) is showing a year-on-year increase as the proportion of the elderly population continues to rise globally. Despite the success of Western medicines in the treatment of OP, the ensuing adverse effects and uncertainty of efficacy remain to be addressed. This has prompted the medical community to actively explore safer and more effective treatments. The field of Traditional Chinese Medicine (TCM) has demonstrated unique advantages in the treatment of osteoporosis. Notably the PI3K/Akt signalling pathway, as a key mechanism regulating bone metabolism and blood circulation, has received extensive attention in recent years. According to Chinese medicine, the pathogenesis of OP is closely related to kidney deficiency and blood stasis. Therefore, from the molecular mechanism of PI3K/Akt signalling pathway, we will discuss how Chinese medicine can establish and maintain a relatively stable "bone balance" between osteoblasts and osteoclasts through the regulation of this key pathway, promote the growth of trabecular number and thickness, and at the same time, reduce the separation of trabeculae, so as to improve the bone balance of patients with OP due to kidney deficiency and blood stasis. This will improve the symptoms and quality of life of OP patients with kidney deficiency and blood stasis.

Research progress and application of OPG/RANK/RANKL signaling pathway in osteoporosis

Research and Application of Target Therapy for Osteoporosis

Role of OPG/RANKL/RANK system during alveolar bone resorption and remodeling

Research Progress of RANK/RANKL/OPG Signaling Pathway

Progress on OPG/RANKL/RANK System

Research Progress of the Molecular Signal Pathway in the Prevention and Treatment of Osteoporosis

Stress Sensitive Signal Pathway Osteoprotegerin/Receptor Activator of Nuclear Factor-κB ligand/Receptor Activator of Nuclear Fac-tor-κB and Osteoporosis (review)

Advances in the occurrence and biotherapy of osteoporosis.

Recent Progresses in the Treatment of Osteoporosis

Research progress on the role of angiogenesis in bone metabolism and osteoporosis

Research progress on drugs in osteoporosis therapy

Targeting proteostasis network in osteoporosis: Pathological mechanisms and therapeutic implications

The Study of Natural Compounds Targeting RANKL Signaling Pathway for the Treatment of Bone Diseases

Structure and Mechanism of OPG & RANK & RANKL and Their Effect on Bone Diseases

Research progress in mechanism of icariin regulating osteoclast differentiation for treatment of osteoporosis

Progress of Wnt Signaling Pathway in Osteoporosis

Overview of the Research Progress of Traditional Chinese Medicine in the Intervention of Kidney Deficiency and Blood Stasis Type Osteoporosis by Regulating the PI3K/Akt Signalling Pathway

RANKL and OPG Regulation on Bone Remodeling

The RAGE signaling in osteoporosis

Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds

Receptor activator of nuclear factor-B ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds